Biofrontera (BFRI) Cash from Operations (2020 - 2025)

Biofrontera's Cash from Operations history runs 6 years deep, the most recent figure standing at 2415000.0 for Q4 2025.

• On a quarterly basis, Cash from Operations fell 141.5% year-over-year to 2415000.0 in Q4 2025; TTM through Dec 2025 was 13400000.0, a 30.1% decrease from a year earlier, with the FY2025 full-year figure at 13400000.0, down 30.1% from the prior year.
• Cash from Operations grew to 2415000.0 in Q4 2025 per BFRI's latest filing, from 3785000.0 in the prior quarter.
• Across five years, Cash from Operations topped out at 113000.0 in Q2 2022 and bottomed at 21000000.0 in Q4 2021.
• The 5-year median for Cash from Operations is 3350000.0 (2021), against an average of 4574750.0.
• Across the five-year window, Cash from Operations soared 110.2% in 2022 and slumped 9215.04% in 2023, its largest moves.
• Year by year, Cash from Operations stood at 21000000.0 in 2021, then surged by 60.48% to 8300000.0 in 2022, then fell by 6.82% to 8866000.0 in 2023, then surged by 88.72% to 1000000.0 in 2024, then sank by 141.5% to 2415000.0 in 2025.
• Per Business Quant, the three latest BFRI Cash from Operations figures stand at 2415000.0 (Q4 2025), 3785000.0 (Q3 2025), and 3083000.0 (Q2 2025).